Feasibility of Early 68 Ga-FAP-2286 PET Imaging: A Case Study.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 39501486.
- Also identified by DOI 10.1097/RLU.0000000000005519.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fibroblast activation protein (FAP) has emerged as a promising molecular target for diagnostic and therapeutic strategies. Previous research, including our own study and other published reports, has highlighted the potential of FAP inhibitors labeled with 68 Ga as effective diagnostic radiopharmaceuticals. In this study, we present a comparative analysis of early and late PET/CT scans, using 68 Ga-FAP-2286, for the detection of tumor lesions in a patient with metastatic breast adenocarcinoma.
Medical subject headings
- Feasibility Studies
- Gallium Radioisotopes
- Positron Emission Tomography Computed Tomography